Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. It is not yet known if selenium is effective in
preventing the growth of new tumors in patients with previously resected non-small cell lung
cancer.
PURPOSE: This randomized phase III trial is studying selenium to see how well it works
compared to a placebo in preventing the development of second primary lung tumors in patients
who have undergone surgery to remove stage I non-small cell lung cancer.
Phase:
Phase 3
Details
Lead Sponsor:
ECOG-ACRIN Cancer Research Group
Collaborators:
Cancer and Leukemia Group B National Cancer Institute (NCI) NCIC Clinical Trials Group North Central Cancer Treatment Group Southwest Oncology Group